Medizest Pharmaceuticals Private Limited

Pharmaceutical company manufacturing drugs, part of Agrawal Group, incorporated in 1987.

1987 | Goa, Goa (India) | Active
Last Updated: November 16, 2024

Medizest Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 4.60 Cr
  • Paid Up Capital ₹ 4.03 Cr
  • Company Age 37 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 2.88 Cr
  • Satisfied Charges ₹ 22.50 Cr
  • Revenue Growth 4.96%
  • Profit Growth 33.46%
  • Ebitda 60.49%
  • Net Worth -8.77%
  • Total Assets 17.23%

About Medizest Pharmaceuticals

Medizest Pharmaceuticals Private Limited (MPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 30 June 1987 and has a history of 37 years and seven months. Its registered office is in Goa, Goa, India.

The Corporate was formerly known as Kare Labs Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.60 Cr and a paid-up capital of Rs 4.03 Cr.

The company currently has active open charges totaling ₹2.88 Cr. The company has closed loans amounting to ₹22.50 Cr, as per Ministry of Corporate Affairs (MCA) records.

Anirudh Agrawal, Anurag Agrawal, and Krishnakumar Agrawal serve as directors at the Company.

Company Details

Corporate Identity Details

  • CIN/LLPIN

    U24232GA1987PTC007465

  • Company No.

    007465

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    30 Jun 1987

  • Date of AGM

    25 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Goa

Industry

Pharma

Who are the key members and board of directors at Medizest Pharmaceuticals?

Executive Team (1)

NameDesignationAppointment DateStatus
Anurag Agrawal Country flag representing In Managing Director04-Aug-2011Current

Board Members (2)

NameDesignationAppointment DateStatus
Anirudh Agrawal Country flag representing In Director 04-Aug-2011Current
Krishnakumar Agrawal Country flag representing In Director 04-Aug-2011Current

Financial Performance of Medizest Pharmaceuticals.

Medizest Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.96% increase. The company also saw a substantial improvement in profitability, with a 33.46% increase in profit. The company's net worth dipped by a decrease of 8.77%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
4.96%
Revenue from Operations
3.08%
Total Assets
17.23%
Profit or Loss
33.46%
Net Worth
-8.77%
EBITDA
60.49%

What is the Ownership and Shareholding Structure of Medizest Pharmaceuticals?

In 2023, Medizest Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹2.88 Cr

Satisfied Charges

₹22.50 Cr

Charges Breakdown by Lending Institutions

  • Others : 2.65 Cr
  • Goa Urban Co-0P. Bank : 0.23 Cr

Latest Charge Details

DateLenderAmountStatus
28 Nov 2014Others₹2.65 CrOpen
30 Apr 1997Goa Urban Co-0P. Bank₹2.30 MOpen
09 Feb 2017Others₹8.50 MSatisfied
26 Nov 2009Idbi Bank Limited₹10.00 CrSatisfied
27 Nov 2006Small Industries Development Bank Of India₹2.50 MSatisfied

How Many Employees Work at Medizest Pharmaceuticals?

Medizest Pharmaceuticals has a workforce of 70 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medizest Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medizest Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Medizest Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Medizest Pharmaceuticals Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records.

    25 Sep 2024

  • Balance Sheet

    Medizest Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Goa.

    31 Mar 2024

  • Charges

    A charge registered on 09 Feb 2017 via Charge ID 100091563 with Others was fully satisfied on 14 Mar 2024.

    14 Mar 2024

  • Charges

    A charge registered on 04 Nov 2004 via Charge ID 90075817 with Edc Limited was fully satisfied on 29 May 2020.

    29 May 2020

  • Charges

    A charge with Others of Rs. 2.65 Cr registered on 28 Nov 2014 with Charge ID 10628473 was modified on 10 Feb 2017.

    10 Feb 2017

  • Charges

    A charge with Others amounted to Rs. 0.85 Cr with Charge ID 100091563 was registered on 09 Feb 2017.

    09 Feb 2017

Frequently asked questions

  • Medizest Pharmaceuticals Private Limited was incorporated on 30 Jun 1987.

  • The authorized share capital of Medizest Pharmaceuticals Private Limited is ₹ 4.60 Cr and paid-up capital is ₹ 4.03 Cr.

  • Currently 3 directors are associated with Medizest Pharmaceuticals Private Limited.

    • Anirudh Krishnakumar Agrawal
    • Anurag Agrawal
    • Krishnakumar Gangadhar Agrawal
  • As per Ministry of Corporate Affairs (Mca), the registered address of Medizest Pharmaceuticals Private Limited is L-40, Industrial Estate Salcete India, Verna, Goa, 403722.

  • The corporate identification number (CIN) of Medizest Pharmaceuticals Private Limited is U24232GA1987PTC007465 and the company number is 007465 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Medizest Pharmaceuticals Private Limited is https://www.agrawalgroupgoa.com

  • According to the financial reports for the fiscal year 2023, the revenue trend for Medizest Pharmaceuticals Private Limited has risen by 4.96%.

  • As Per 2023 financial reports, 70 employees are currently employed by Medizest Pharmaceuticals Private Limited.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Medizest Pharmaceuticals Private Limited has experienced an downturn of -8.77%.

  • As per the financial statements for fiscal Year 2023, The total open charges for Medizest Pharmaceuticals Private Limited amount to ₹ 2.88 Cr.

  • The most recent Balance Sheet for Medizest Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development